STRIDES PHARMA SCI LTD (STAR)

NSE: ₹1,027.20
BSE: ₹1,027.35
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Intimation of Schedule of Analyst/ Institutional Investors Meet

2026-06-08 20:15:52
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 – Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPF

Reminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF

2026-06-01 21:45:19
Intimation Of Effective Date For The Scheme Of Demerger Involving Arco Lab Private Limited (“Arco Lab”) And Pivot Path Private Limited (“Pivot Path”)

Intimation of Effective Date for Scheme of Demerger involving Arco Lab Private Limited ("Arco Lab") and ("Pivot Path Private Limited").

2026-06-01 17:34:03
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Schedule of Analyst/ Institutional Investor's Meeting - as enclosed.

2026-05-28 20:11:00
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Schedule of Analyst/ Institutional Investor's Meet - as enclosed.

2026-05-28 20:07:32
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Schedule of Analyst/ Institutional Investor's meet - as enclosed

2026-05-28 20:05:01

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 475.32 540.29 520.02 617.63 554.75 609.96 550.92 555.96 498.62 522.15 553.63 605.74
YOY Revenue Growth % 12.32% 12.27% 34.54% 9.6% 16.71% 12.89% 5.94% -9.99% -10.12% -14.4% 0.49% 8.95%
Other Income 11.65 22.34 8.69 29.63 11.83 23.55 2.43 12.12 1.76 14.09 103.24 3.97
Total Income 486.97 562.63 528.70 647.27 566.58 633.50 553.35 568.08 500.37 536.24 656.88 609.71
Total Expenses + 477.84 558.43 519.89 594.41 560.92 619.06 531.95 539.76 483.97 510.86 522.07 583.20
Cost of Materials Consumed 215.10 288.94 302.14 266.45 253.77 301.91 295.26 268.29 210.98 255.66 255.50 297.46
Employee Benefit Expense 76.70 86.25 85.66 86.60 94.87 96.76 93.80 91.86 94.04 96.49 95.14 95.94
Other Expenses 113.19 117.84 96.55 128.72 119.41 134.63 103.45 113.92 95.16 81.42 104.95 121.95
Operating Profit -2.52 -18.15 0.13 23.22 -6.17 -9.11 18.97 16.20 14.65 11.30 31.56 22.54
OPM % -0.5% -3.4% 0% 3.8% -1.1% -1.5% 3.4% 2.9% 2.9% 2.2% 5.7% 3.7%
Profit Before Tax + 9.13 4.19 3.52 52.78 5.66 14.43 21.38 28.32 16.40 25.39 134.80 26.51
Tax Expense 1.13 2.91 0.98 -0.89 1.75 -0.88 6.44 12.20 3.06 -6.65 12.91 10.16
Tax % 12.3% 69.4% 27.8% -1.7% 30.8% -6.1% 30.1% 43.1% 18.6% -26.2% 9.6% 38.3%
Profit After Tax 8.00 1.28 2.54 53.66 3.92 15.31 14.94 16.13 13.35 32.04 121.90 16.35
EPS (Basic) 0.89 0.14 0.28 5.84 0.43 1.66 1.62 1.75 1.45 3.48 13.22 1.77

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 2,180.14 2,139.42 2,153.26 1,854.50 1,979.00 1,857.57 1,674.15
YOY Revenue Growth % 1.9% -0.64% 16.11% -6.29% 6.54% 10.96% -
Other Income 123.06 46.19 72.31 84.07 123.49 89.00 100.16
Total Income 2,303.20 2,185.61 2,225.56 1,938.56 2,102.49 1,946.56 1,774.31
Total Expenses + 2,100.10 2,107.50 2,150.58 1,988.32 2,080.98 1,834.93 1,424.47
Cost of Materials Consumed 1,019.60 1,048.11 1,072.63 1,020.10 935.42 1,050.10 848.34
Employee Benefit Expense 381.60 377.59 335.21 267.01 272.09 272.72 221.77
Other Expenses 403.47 415.86 456.30 423.40 528.77 408.65 354.36
Operating Profit 80.04 31.92 2.68 -133.83 -101.98 22.64 249.68
OPM % 3.7% 1.5% 0.1% -7.2% -5.2% 1.2% 14.9%
Profit Before Exceptional 203.10 78.11 74.99 -49.76 21.51 111.64 151.86
Exceptional Items 0.00 -0.03 -5.37 -15.00 0.00 0.00 0.00
Profit Before Tax + 203.10 78.08 69.62 -64.76 21.51 111.64 151.86
Tax Expense 19.47 -2,808.13 4.13 -69.44 -158.68 33.40 40.16
Tax % 9.6% -3596.3% 5.9% - -737.8% 29.9% 26.4%
Profit After Tax 183.64 2,886.21 65.49 4.68 180.19 78.24 111.70
EPS (Basic) 19.92 313.68 7.20 0.52 20.08 8.73 12.47

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 3,022.13 2,885.44 3,421.93 3,493.34 3,458.61 3,477.48 0.00
Property, Plant & Equipment 634.20 606.42 507.87 555.67 567.95 536.09 0.00
Capital Work in Progress 83.99 65.74 57.71 15.79 30.45 81.36 0.00
Non-Current Investments 1,868.28 1,847.69 2,498.34 2,491.77 2,399.76 2,394.65 0.00
Goodwill 115.58 115.58 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 35.05 34.02 36.72 28.63 36.14 40.57 0.00
Current Assets + 2,373.59 2,145.50 2,415.86 2,126.40 1,975.25 1,743.86 0.00
Inventories 580.27 431.71 470.18 490.76 513.06 689.08 0.00
Trade Receivables 1,521.28 1,452.93 1,508.51 1,307.78 1,296.32 821.67 0.00
Cash and Cash Equivalents 16.17 6.33 92.71 82.11 12.12 25.30 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 3,283.52 3,192.74 3,561.12 3,455.05 3,406.68 3,248.06 0.00
Equity Share Capital 92.17 92.16 91.90 90.30 89.79 89.68 0.00
Other Equity 3,191.35 3,100.57 3,469.22 3,364.75 3,316.89 3,158.38 0.00
Non-Current Liabilities 272.13 208.60 281.36 367.86 185.85 382.64 0.00
Current Liabilities 1,840.07 1,629.61 1,995.30 1,796.83 1,841.32 1,590.64 0.00
Total Liabilities 2,112.20 1,838.21 2,276.66 2,164.69 2,027.18 1,973.28 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 277.85 421.48 -35.76 241.74 -282.69 282.76 0.00
Cash from Investing Activities -69.07 -137.59 -61.27 -182.58 18.78 -275.64 0.00
Cash from Financing Activities -198.93 -370.32 107.62 10.82 250.73 -48.64 0.00
Net Increase/Decrease in Cash 9.84 -86.42 10.60 69.98 -13.18 -41.52 0.00